Treatment of genital endometriosis in women of late reproductive and premenopausal age

О Б Калинкина; Yu. V. Tezikov

doi:10.17116/repro2015214110-113

Treatment of genital endometriosis in women of late reproductive and premenopausal age

О Б Калинкина, Yu. V. Tezikov

In: Problemy reproduktsii · 2015 · vol. 21(4) , pp. 110 · doi:10.17116/repro2015214110-113 · W2322941716

article OA: closed CC0

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex

⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This paper investigated the effectiveness of various treatments for genital endometriosis in women aged 35-55.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (15)

Altered expression of a cell-cycle suppressor gene, Tob-1, in endometriotic cells by cDNA array analyses via openalex
Dienogest inhibits BrdU uptake with G0/G1 arrest in cultured endometriotic stromal cells via openalex
Endometriosis via openalex
High rates of autoimmune and endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic diseases among women with endometriosis: a survey analysis via openalex
Long-term use of progestogens – effects on endometriosis, adenomyosis and myomas via openalex
Progestagens and anti-progestagens for pain associated with endometriosis via openalex
Progesterone receptor polymorphism +331G/A is associated with a decreased risk of deep infiltrating endometriosis via openalex
Somatic DNA alterations in endometriosis: high frequency of chromosome 17 and p53 loss in late-stage endometriosis via openalex
The Epidemiology of Endometriosis via openalex
W6641127482 via openalex
W2002687754 via openalex
W2045458073 via openalex
W2151271656 via openalex
W4211081176 via openalex
W1551538692 via openalex

Source provenance

openalex: last seen: 2026-06-10T17:14:06.276822+00:00

License: CC0 · commercial use OK

[1] Altered expression of a cell-cycle suppressor gene, Tob-1, in endometriotic cells by cDNA array analyses via openalex

[2] Dienogest inhibits BrdU uptake with G0/G1 arrest in cultured endometriotic stromal cells via openalex

[3] Endometriosis via openalex

[4] High rates of autoimmune and endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic diseases among women with endometriosis: a survey analysis via openalex

[5] Long-term use of progestogens – effects on endometriosis, adenomyosis and myomas via openalex

[6] Progestagens and anti-progestagens for pain associated with endometriosis via openalex

[7] Progesterone receptor polymorphism +331G/A is associated with a decreased risk of deep infiltrating endometriosis via openalex

[8] Somatic DNA alterations in endometriosis: high frequency of chromosome 17 and p53 loss in late-stage endometriosis via openalex

[9] The Epidemiology of Endometriosis via openalex

[10] W6641127482 via openalex

[11] W2002687754 via openalex

[12] W2045458073 via openalex

[13] W2151271656 via openalex

[14] W4211081176 via openalex

[15] W1551538692 via openalex